Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8502, Japan.
Acta Neuropathol. 2010 Apr;119(4):481-6. doi: 10.1007/s00401-010-0660-7. Epub 2010 Feb 24.
Congenital myotonic dystrophy (CDM) is associated with markedly expanded CTG repeats in DMPK. The presence of numerous immature fibers with peripheral halo is a characteristic feature of CDM muscles together with hypotrophy of type 1 fibers. Smaller type 1 fibers with no structural abnormality are a definitive criterion of congenital fiber type disproportion (CFTD). Nonetheless, we recently came across a patient who was genetically confirmed as CDM, but had been earlier diagnosed as CFTD when he was an infant. In this study, we performed clinical, pathological, and genetic analyses in infantile patients pathologically diagnosed as CFTD to evaluate CDM patients indistinguishable from CFTD. We examined CTG repeat expansion in DMPK in 28 infantile patients pathologically diagnosed as CFTD. Mutation screening of ACTA1 and TPM3 was performed, and we compared clinical and pathological findings of 20 CDM patients with those of the other cohorts. We identified four (14%) patients with CTG expansion in DMPK. ACTA1 mutation was identified in four (14%), and TPM3 mutation was found in two (7%) patients. Fiber size disproportion was more prominent in patients with ACTA1 or TPM3 mutations as compared to CFTD patients with CTG expansion. A further three patients among 20 CDM patients showed pathological findings similar to CFTD. From our results, CDM should be excluded in CFTD patients.
先天性肌强直性营养不良(CDM)与 DMPK 中的明显扩大的 CTG 重复有关。存在具有周围晕圈的大量不成熟纤维是 CDM 肌肉的特征性特征,同时伴有 1 型纤维萎缩。没有结构异常的较小 1 型纤维是先天性纤维类型比例失调(CFTD)的明确标准。尽管如此,我们最近遇到了一位患者,他的基因被证实为 CDM,但在婴儿时期曾被诊断为 CFTD。在这项研究中,我们对病理诊断为 CFTD 的婴儿患者进行了临床、病理和遗传分析,以评估与 CFTD 无法区分的 CDM 患者。我们在 28 例病理诊断为 CFTD 的婴儿患者中检查了 DMPK 中的 CTG 重复扩展。进行了 ACTA1 和 TPM3 的突变筛查,并比较了 20 例 CDM 患者与其他队列的临床和病理发现。我们确定了 4 名(14%)DMPK 中的 CTG 扩展患者。在 4 名(14%)患者中发现了 ACTA1 突变,在 2 名(7%)患者中发现了 TPM3 突变。与 CTG 扩展的 CFTD 患者相比,具有 ACTA1 或 TPM3 突变的患者的纤维大小比例失调更为明显。在 20 例 CDM 患者中,另外 3 例患者的病理表现类似于 CFTD。根据我们的结果,CFTD 患者应排除 CDM。